Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.1
4.9
Journals
IJMS
Special Issues
The Role of Cytokines in Health and Diseases
ijms-logo
Submit to Special Issue Submit Abstract to Special Issue Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

The Role of Cytokines in Health and Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 July 2025 | Viewed by 470

Special Issue Editor

Dr. Hung-Jen Liu

E-Mail Website
Guest Editor
Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan
Interests: virus–host interaction; signal transduction; cancer virotherapy; vaccine development; cytokines; anti-tumor immunity

Special Issue Information

Dear Colleagues,

I am delighted to announce a new Special Issue of International Journal of Molecular Sciences, entitled “The Role of Cytokines in Health and Diseases”.

Cytokines are key regulators of immune responses, playing essential roles in both health and disease. These signaling molecules mediate inflammation, tissue repair, and immune homeostasis, but their dysregulation contributes to various pathological conditions, including autoimmune diseases, infections, and cancer. In the tumor microenvironment, cytokines can either promote or suppress tumor progression by modulating immune cell activity. Recent research highlights their role in shaping anti-tumor immunity, influencing responses to immunotherapy, and mediating tumor-induced immune evasion. Moreover, cytokines are critical in pain modulation and neuroimmune interactions, particularly in the context of anesthesia and perioperative medicine.

This Special Issue aims to explore the diverse functions of cytokines, from fundamental biology to clinical applications, shedding light on their therapeutic potential in disease management. We welcome original research and reviews that advance our understanding of cytokine signaling in health and disease, with a particular focus on translational and clinical implications. However, since International Journal of Molecular Sciences is a journal of molecular science, pure clinical studies are not suitable for our journal.

This Special Issue is supervised by Dr. Hung-Jen Liu and assisted by Dr. Yi-Ying Wu (National Chung Hsing University).

Dr. Hung-Jen Liu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cytokines
  • immune regulation
  • disease management
  • signaling pathways
  • translational research
  • clinical applications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

23 pages, 5802 KiB  
Article
Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer
by Yi-Ying Wu, Ming-Shan Chen, I-Chun Chen, Feng-Hsu Wu, Tsai-Ling Liao, Hsiao-Wei Wen, Brent L. Nielsen and Hung-Jen Liu
Int. J. Mol. Sci. 2025, 26(7), 3236; https://doi.org/10.3390/ijms26073236 - 31 Mar 2025
Viewed by 428
Abstract
Lidocaine, a local anesthetic, has been shown to modulate immune responses. This study examines its effects on cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy donors and tumor-infiltrating immune cells (TIICs) from gastric cancer patients. PBMCs from healthy donors and TIICs [...] Read more.
Lidocaine, a local anesthetic, has been shown to modulate immune responses. This study examines its effects on cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy donors and tumor-infiltrating immune cells (TIICs) from gastric cancer patients. PBMCs from healthy donors and TIICs from gastric cancer patients were treated with lidocaine. Cytokine production was assessed using flow cytometry and cytokine assays, with a focus on IFN-γ, IL-12, IL-10, TGF-β, and IL-35 levels. Cytotoxicity against primary gastric cancer cells (PGCCs) was also evaluated. Lidocaine inhibited IFN-γ production in CD8+ PBMCs and IL-12 in CD14+ PBMCs while increasing anti-inflammatory cytokines (IL-10, TGF-β, IL-35) in CD4+CD25+ and CD14+ cells. In TIICs, lidocaine enhanced IFN-γ and IL-12 production in CD8+ and CD14+ cells while reducing IL-10, TGF-β, and IL-35 levels, promoting an M1-like phenotype in macrophages. Mechanistically, lidocaine enhanced IFN-γ production in sorted CD8+ TIICs through G-protein-coupled receptor (GPCR) signaling and increased IL-12 production in sorted CD14+ TIICs via the toll-like receptor 4 (TLR4) signaling pathway. Lidocaine also increased IFN-γ production and cytotoxicity in CD8+ TIICs via NF-κB activation. Importantly, lidocaine did not affect the viability of PBMCs, TIICs, or PGCCs at concentrations up to 1.5 mM. Lidocaine reprogrammed the tumor immune microenvironment, enhancing anti-tumor immune responses, suggesting its potential to modulate immune functions in gastric cancer. Full article
(This article belongs to the Special Issue The Role of Cytokines in Health and Diseases)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop